Interview with Nihal Aygun, CEO, Corena Turkey
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a professional experience in several…
ImuneksFarma currently has three healthcare segments; OTC, Pharma (RX), and R&D.
Imuneks’ OTC portfolio is concentrated in the immunology, Ear Nose and Throat, Gastroenterology, Orthopedics and PT areas. These products all have unique benefits to the patients, and are either developed by Imuneks, or by partners with best in class products.
In the RX area, Imuneks has developed three supergeneric products which are already approved in the EU and US markets. These products have improved ease of use, increased efficiency and diminished side effects.
The Imuneks R&D team is working with more than five original pharmaceutiaal treatments and five unique OTC products that are in the pipeline. With two internationally approved patents and a portfolio of new patent applications in different indications, Imuneks Farma is always looking for new and improved ways to treat and cure.
Prof. Dr. Bülent Tarcan Cad.Pak İş Merkezi No:5 Gayrettepe / İstanbul
Contact us at http://www.imuneksfarma.com/
Mrs Aygun, could you please introduce yourself to our readers and give us an overview of CORENA? I have an educational background in chemistry and a professional experience in several…
You are among the youngest GM’s of the top 200 companies in Turkey. What factors would you attribute to the rapid advancement of your career? I would say that there…
Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to the merger of the…
Mr Yusuf, Pharmaceutical Executive’s readers are keen to discover, through our reports, prominent industry personalities, and they like to hear their stories. Having been instrumental in the formation of the…
IEIS is an association with dual responsibilities. Promotion of generic usage in turkey and ensuring the sustained development of a local manufacturing industry. Before we look into these two aspects,…
Even though you have delivered strong results in most of the markets you have been appointed, this is your first assignment as the head of a subsidiary. For a man…
We are here with a very young company, created in 2009, so only three years old. As you mentioned before the interview, you first started to work in the medical…
Before we start with the interview I noticed that previously you were in charge of other regions aside from turkey. Is that still the case? If not why did IMS…
Mr Sözeri, Pharmaceutical Executive’s readers are keen to discover, through our reports, prominent industry personalities, and they like to hear their stories. You have an outstanding career, having worked for…
Could you introduce the organisation and its objectives to our readers? The International Investors Association of Turkey (YASED) is a non-governmental organization whose members are international companies operating in Turkey.…
Turkey remains a country between two worlds. Not only is it straddled between Asia and Europe, it also boasts a very strong and modern “western” industry and infrastructure together with…
See our Cookie Privacy Policy Here